* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Curriculum Vitae: Rachel Lampert
Survey
Document related concepts
Cardiovascular disease wikipedia , lookup
Heart failure wikipedia , lookup
Remote ischemic conditioning wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Jatene procedure wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Coronary artery disease wikipedia , lookup
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Cardiac surgery wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Transcript
Curriculum Vitae: Rachel Lampert Address: home: 43 Linden Ave Branford, CT 06405 phone: (203) 488-4946 Section of Cardiology, Yale University School of Medicine 333 Cedar Street, FMP 3 New Haven, CT 06520 phone (203) 737-4068 work: Birthdate: September 26, 1961 Education: Phillips Academy 1979 Andover, MA Harvard College BA, 1983 Cambridge, MA Vanderbilt Medical School MD, 1987 Nashville, TN Post Graduate Experience July ‘87-June ‘88: Intern, Internal Medicine Bellevue/New York University Medical Center; New York, NY July ‘88-June’90: Resident, Internal Medicine Bellevue/ New York University Medical Center July ‘90-June ‘91: Chief Resident, Internal Medicine Bellevue/New York University Medical Center July ‘91-July ‘92: Visiting physician/professor Hospital-Escuela Oscar Danilo Rosales A. Universidad Nacional Autonoma de Nicaragua; Leon, Nicaragua July ‘92-June '96: Clinical Fellow, Section of Cardiovascular Medicine, Yale-New Haven Hospital; New Haven, CT Employment July ‘96-June ‘97 Clinical Instructor of Medicine, July ‘97-June ‘01 Assistant Professor of Medicine July ‘01-June ‘03 Associate Research Scientist July ’03-June ‘05 Assistant Professor of Medicine July ’05-present Associate Professor of Medicine Section of Cardiovascular Medicine Yale School of Medicine, New Haven, CT Certifications: National Board of Medical Examiners 1988 American Board of Internal Medicine 1990 ABIM, Cardiovascular Diseases 1995, 2005 ABIM, Clinical Cardiac Electrophysiology, 1998, 2008 Memberships: Fellow, American College of Cardiology Fellow, Heart Rhythm Society Grant Review Committees: American Heart Association, National: Electrophysiology and Arrhythmias, spring 2004-fall 2007 AHA, Heritage Affiliate: Clinically Applied Research, spring 2004, spring 2006 AHA, Region I: Electrophysiology and Arrhythmias, Co-Chair, 2007-08 Chair, 2008-2010 CT CASE-DPH reviewer spring 2009, spring 2010, fall 2011, fall 2012 FDA Office of Women’s Health, ad hoc reviewer spring 2007 National Institute of Health, MESH, February 10-11, 2005 NIH, 2008/10 ZRG1 CVS-K (10) B - Cardiovascular Sciences Small Business Activities, primary reviewer, spring 2008, fall 2008 NIH ARRA SEPs: ZHL1 CSR-G 02, and ZHL CSR-U(02) , summer 2009 NIH ZHL1 CSR-G F1 1, (ancillary studies) fall 2009, spring 2010, summer 2010, fall 2010 NIH, CICS, spring 2010, fall 2010, appointed standing member spring 2011 Other National Committees: Heart Rhythm Society, Scientific and Clinical Documents Committee, Spring 2005-2012, Vice-Chair, spring 2007-08, Chair, spring 2008-2012 Heart Rhythm Society Task Force for Device Performance, 7/05-10/06; Task force For Lead Performance, 4/08-5/09; Task Force for Device Deactivation at End of Life, Co-Chairman, 10/08-6/10; Task Force on Relationships with Industry, 9/105/11 Heart Rhythm Society, Board of Trustees, spring 2010-spring 2013 Heart Rhythm Society, Women’s Leadership Initiative, 3/07-present Heart Rhythm Society, Ethics Committee, 5/12-present American College of Cardiology, ICD Registry Research and Publications Committee, spring 2007-spring 2013 American College of Cardiology, Scientific Sessions Program Committee (Sports Council), 2012 Journal Peer Reviewer: J Am Coll Cardiol (Elite Reviewer), Circulation, American Journal of Cardiology, PACE, Psychosomatic Medicine, American Heart Journal, J Psychosomatic Research, Journal Cardiovascular Electrophysiology, Heart Rhythm Editorial Board, Psychosomatic Medicine, spring 2010-present J Am Coll Cardiol, 10/10-present ACC Cardiosource Cardiac Rhythm Management Online Community, Editor-in-Chief, spring 2012present Abstract reviewer: American Heart Association 2009, 2010, 2011, 2012 Data Safety and Monitoring Board: Pulse Study, NIH NHLBI (R01 HL081642), PI Funk Modeling Stress-precipitated Smoking Behavior for Medication Development”, McKee SCOR Hospital committees: HVC quality committee Intern selection committee CTSA Science and Safety Committee CTSA biomedical informatics advisory board Publications 1) Published papers in peer-reviewed journals 1. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C: Circadian Variation of Sustained Ventricular Tachycardia in Patients with Coronary Artery Disease and Implantable CardioverterDefibrillators. Circulation 1994; 90:241-247. 2. Lampert R, Rosenfeld L, McPherson C, Lewis R, VanZetta A, Batsford W: Initial Single-Center Experience with an Advanced Third Generation Investigational Defibrillator. PACE 1996; 19:20722082 3. Lampert R, McPherson CA, Lewis RJ, Batsford WP, Rosenfeld LE: Inappropriate Sensing of Atrial Stimuli in Patients with a Third Generation Defibrillator and DDD Pacemaker. PACE 1998; 21: 12251229 4. Lampert R, Jain D, Burg M, Batsford W, McPherson C: Destabilizing effects of mental stress on ventricular arrhythmias in patients with Implantable Cardioverter-defibrillators. Circulation 2000; 101:158-164 5. Jain D, Joska T, Lee F, Burg M, Lampert R, Zaret B: Day to Day Reproducibility of Mental Stress Induced Left Ventricular Dysfunction in Patients With Coronary Artery Disease and its Relationship to Autonomic Activation. Journal of Nuclear Cardiology; 2001; 8:347-55. 6. Lampert R, Baron S, McPherson C, Lee F: Heart Rate Variability During the Week of September 11, 2001. JAMA, 2002; 288: 575. 7. Lampert R, Joska T, Burg M, Batsford WP, McPherson CA, Jain D: Emotional and Physical Precipitants of Ventricular Arrhythmia. Circulation 2002; 106: 1800-1805 8. Lampert R, Ickovics JR, Viscoli CJ, Horwitz RI, Lee FA: Effects of Propranolol on Recovery of Heart Rate Variability Following Acute Myocardial Infarction and Relation to Outcome in the BetaBlocker Heart Attack Trial. Am J Cardiol 2003;91 :137-142 9. Koul AK, Keller S, Clancy JF, Lampert R, Batsford WP, Rosenfeld LE. Hyperkalemia induced T wave oversensing leading to loss of bi-ventricular pacing and inappropriate ICD shocks. PACE; 27: 681-683, 2004. 10. Lampert R, McPherson CA, Clancy JF, Caulin-Glaser T, Rosenfeld LE, Batsford, WP: Gender Differences in Ventricular Arrhythmia Recurrence in Patients with Coronary Artery Disease and Implantable Cardioverter Defibrillators. J Am Coll Cardiol 2004; 43/12: 2293-2299 11. Schreibman, Rosenfeld, McPherson, Batsford, Lampert: Usefulness of Procainamide Challenge for Electrophyiologic Arrhythmia Risk Stratification. Am J Cardiol, 2004; 94:1435-1438. 12. Burg, M, Lampert, R, Joska, T, Batsford, W, Jain, D. Psychological Traits and Emotion-triggering of ICD Shock-terminated Arrhythmias. Psychosomatic Medicine, 2004;66:898-902. 13. Lampert, R, Ickovics, J, Horwitz, R. Lee, F.: Depressed Autonomic Nervous System Function in African-Americans and Individuals of Lower Social Class: A Potential Mechanism of Race and ClassRelated Disparities in Health Outcomes. Am Heart J 2005; 150:153-60 14. Goldstein, NE, Lampert, R, Bradley, E, Lynn, J, Krumholz, HM: Management of CardioverterDefibrillators in End-of-Life Care. Annals Intern Med 2005; 141:835-838. 15. Lampert, R, Shusterman, V, Burg, M, Lee, F, Earley, C, Goldberg, A, McPherson, C, Batsford, W, Soufer, R: Effects of Psychologic Stress on Repolarization and Relationship to Autonomic and Hemodynamic Factors. J Cardiovasc Electrophysiology; 2005; 16: 372-377. 16. Whang , W, Albert, C, Sears, S, Lampert, R, Conti, J, Wang, P, Singh, J, Ruskin, J, Muller, J, Mittleman, M, for the TOVA investigators: Depression as a Predictor for Appropriate Shocks among Patients with Implantable Cardioverter-Defibrillators: Results from the Triggers of Ventricular Arrhythmias (TOVA) Study. J Am Coll Cardiol, 2005; 45:1090-1095 17. Davids JS. McPherson CA. Earley C. Batsford WP. Lampert R. Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey. Archives of Physical Medicine & Rehabilitation, 2005. 86:1924-8 18. Goldberger, Z, Elbel, B, McPherson, C, Paltiel, AD, Lampert R. Cost Advantage of Dual versus Single Chamber Cardioverter Defibrillator Implantation. J Am Coll Cardiol, 2005; 46:850-7. 19. Lampert, R, Cannom, D, Olshansky, B. Safety of Sports in Patients with Implantable Cardioverterdefibrillators: A Survey of Heart Rhythm Society Members. J Cardiovasc Electrophysiol, 2006; 17:1-5. 20. Shah, R, Burg, M, Vashist, A, Collins, D, Liu, J, Jadbabie, F, Graeber, B, Earley, C, Lampert, R, Soufer, R. C-Reactive Protein and Vulnerability to Mental-Stress-Induced Myocardial Ischemia. Molecular Medicine, 2006;12:269-274 21. Stopper, M,Joska, T, Burg, M, Batsford, W, McPherson, C, Jain, D, Lampert, R. Electrophysiologic Characteristics of Anger-triggered Arrhythmias. Heart Rhythm, 2007; 4:268-73. 22. Dewland, T, Androne, A, Lee, F, Lampert, R, Katz, S. Effect of Acetylcholinesterase Inhibition with Pyridostigmine on Cardiac Parasympathetic Function in Sedentary Adults and Trained Athletes. American Journal of Physiology - Heart & Circulatory Physiology, 2007, 293:H86-92. 23. Lampert, R, Soufer, R, McPherson, CA, Batsford, WP, Tirado, S, Earley, C, Goldberg, A, Shusterman, V. Implantable cardioverter-defibrillator shocks increase T-wave alternans. J Cardiovasc Electrophysiol, 2007: 18:512-517 24. Vaccarino V, Lampert R, Bremner JD, Lee FA, Su S, Maisano C, Murrah NV, Jones L, Jawed F, Afzal N, Ashraf A, Goldberg J: Depressive symptoms and heart rate variability: Evidence for a shared genetic substrate in a study of twins. Psychosom Med, 2008: 70:628-636 25. Lampert, R, Bremner, JD, Su, Shaoyong, Miller, A,Lee, F, Cheema, F, Goldberg, J, Vaccarino, V: Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. American Heart Journal, 2008: 156(4): 759.e1–759.e7 26. Hauser, RG, Maron, BJ, Marine, JE, Lampert, R, Kadish, A, Winters, S, Scher, DL, Biria, M, Kalia, A: Safety and efficacy of high voltage implantable cardioverter defibrillator leads in high-risk hypertrophic cardiomyopathy patients. Heart Rhythm, 2008:1517-22. 27. Gehi, A, Lampert, R, Veledar, E, Lee, F, Goldberg, J,; Jones, L, Murrah, N,; Ashraf, A, Vaccarino, V: A Twin Study of Metabolic Syndrome and Autonomic Tone. J Cardiovasc Electrophysiol, 2009: 422-8 28. Lampert, R., Shusterman, V, Burg, M, Batsford, W, McPherson, C, Soufer, R.: Anger-induced Twave alternans predicts future ventricular arrhythmias in patients with implantable cardioverterdefibrillators, JACC, 2009: 53:774-8 29. Curtis, JP, Luebbert, J, Wang, Y, Rathore, SS, Chen, J, Heidenreich, PA, Hammill, SC, Lampert, R, Krumholz, HM: Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA, 2009: 301:1661-1670 30. Mendu, ML, McAvay, G, Lampert, R, Stoehr, J, Tinetti, M: Yield of Diagnostic Tests in Evaluating Syncopal Episodes in Older Patients. Archives Int Med, 2009: 169:1299-1305 31. Burg MM., Graeber B., Vashist A., Collins D., Earley C., Liu J., Lampert R., Soufer R.: Noninvasive detection of risk for emotion-provoked myocardial ischemia.. Psychosomatic Medicine, 2009:14-20 32. Su S., Lampert R., Zhao J., Bremner JD., Miller A,. Snieder H., Lee F,. Khan D,. Goldberg J., Vaccarino V. : Pleiotropy of C-reactive protein gene polymorphisms with C-reactive protein levels and heart rate variability in healthy male twins. American Journal of Cardiology, 2009: 104:1748-54 33. Donahue, RG, Lampert, R, Dornelas, E, Clemow, L, Burg, MM: Rationale and Design of a Randomized Clinical Trial Comparing Stress Reduction Treatment to Usual Cardiac Care: The Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) Trial. Psychosomatic Medicine, 2010: 72:172-77. 34. Lampert, R, Salberg, L, Burg, MM: Emotional triggering of symptoms in hypertrophic cardiomyopathy: A survey of the Hypertrophic Cardiomyopathy Association (HCMA). PACE, 2010, 33:1047-53 35. Friedman, RSC, Burg, MM, Miles, P, Lee, F, Lampert, R: Effects of Reiki on autonomic activity early after acute coronary syndrome. J Am Coll Cardiol, 2010:56:995-6. 36. Dai, J, Lampert, R, Wilson, PW, Goldberg, J, Ziegler, TR, Vaccarino, V: Mediterranean Dietary Pattern Is Associated With Improved Cardiac Autonomic Function Among Middle-Aged Men: A Twin Study. Circ Cardiovasc Qual Outcomes 3(4):366-73, 2010 Jul 37. Razak, E, Buncova, M, Shusterman, V, Winter, B, Shen, W, Ackerman, M, Donovan, T, Lampert, R, Nemec, J. Slow QT interval adaptation to heart rate change in normal ambulatory subjects. Annals Noninvasive Cardiology, in press 38. Su S. Lampert R. Lee F. Bremner JD. Snieder H. Jones L. Murrah NV. Goldberg J. Vaccarino V. Common genes contribute to depressive symptoms and heart rate variability: The Twins Heart Study. Twin Research & Human Genetics. 13(1):1-9, 2010 Feb. 39. Gravelin, LM, Yuhas, J, Remetz, M, Radford, M, Foley, J, Lampert, R: Use of a screening tool improves appropriate referral for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Circ Cardiovasc Qual Outcomes, 2011. 4:152-156 40. Burg, MM, Soufer, A, Lampert, R, Collins, D: Autonomic contribution to endothelin-1 increase during laboratory anger-recall stress in patients with coronary artery disease. Molecular Medicine, 17(56):495-501 41. Shah, AJ, Su, S, Veledar, E, Bremner, JD, Goldstein, FC, Lampert, R, Goldberg, J, Vaccarino, V: Is heart rate variability related to memory performance in middle-aged men? Psychosomatic Medicine, 2011; 73(6):475-82 42. Abisse, SS, Lampert, R, Burg, M, Soufer, R, Shusterman, V: Cardiac repolarization instability during psychological stress in patients with ventricular arrhythmias. J Electrocardiology, 2011. 44: 678683 43. Ashare R., Sinha R., Lampert R., Weinberger A.H., Anderson G., Lavery M., Yanagisawa, K., McKee S.A: Blunted vagal reactivity predicts stress-precipitated tobacco smoking. Psychopharmacology, 220(2):259-68, 2012 44. Cheng, A, Wang, Y, Berger, RD, Calkins, H, Buxton, AE, Curtis, JP, Lampert, R: Electrophysiology studies in patients undergoing ICD implantation: Findings from the NCDR. PACE, 2012, 35:912–918 45. Bhatt, P, Curtis, J, Wang, Y, Lampert, R: Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: Data from the NCDR ICD Registry. J Cardiovasc Electrophys 2012. 23: 861-65. 46. Yuhas, J, Mattocks, K, Gravelin, L, Remetz, M, Foley, J, Fazio, R, Lampert, R. Patient attitudes and perceptions of implantable cardioverter-defibrillators: Potential barriers to appropriate primary prophylaxis. PACE, 2012; 35:1179–1187 47. Dodson JA, Fried TR, Van Ness PH, Goldstein N, Lampert R. Patient Preferences for Deactivation of Implantable Cardioverter Defibrillators. JAMA Internal Medicine. 2013 173(5):377-9 (Archives of Internal Medicine) 48. Lampert, R; Wang, YF, Curtis, JP. Variation among hospitals in selection of higher-cost, “highertech”, implantable cardioverter-defibrillators: Data from the NCDR ICD Registry™. American Heart Journal 2012: 165: 1015-1023. 49. Shah, AJ, Lampert, R; Goldberg, J; Veledar, E; Bremner, JD, Vaccarino, V: Posttraumatic Stress Disorder and Autonomic Inflexibility in Male Twins. Biological Psychiatry 2013: 73: 1103-1110 50. Mandawat, A, Curtis, JP, Mandawat, A, Njike, V, Lampert, R: Safety of Pacemaker Implantation in Nonagenarians: An Analysis of the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample. Circulation, 2013, 127(14):1453-65 51. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, Calkins H, Estes NAM, Link MS, Maron BJ, Marcus F, Scheinman M, Wilkoff BL, Zipes DP, Berul CI, Cheng A, Law I, Loomis M, Barth C, Brandt C, Dziura J, Li F, Cannom D. Safety of sports for athletes with implantable cardioverter-defibrillators: Results of a prospective, multinational registry. Circulation. 2013;127:2021-2030 52. Udo, T, Weinberger, AH, Grilo, CM, Brownell, KD, DiLeone, RJ, Lampert, R, Matlin, SL, Yanagisawa, K, McKee, SA. Heightened Vagal Activity during High-Calorie Food Presentation in Obese compared with Non-obese Individuals - Results of a Pilot Study. Obesity Research & Clinical Practice, 2013, in press 53. Russo, AM, Wang, Y, Curtis, J, Al-Khatib, S, Lampert, R. Contemporary Patterns of Practice Related to Defibrillation Testing and Adverse Events during Implantable CArdioverter Defibrillator Insertion: Analysis of the NCDR ICD Registry. PACE, 2013, in press 54. Winkler, C, Funk, M; Schindler, DM, Hemsey, JZ, Lampert,R, Drew, B. Arrhythmias in Patients with Acute Coronary Syndrome in the First 24 Hours of Hospitalization. Heart and Lung, in press 55. Wagner, J, Lampert, R, Tennen, H, Feinn, R. Exposure to Discrimination and Heart Rate Variability Reactivity to Acute Stress among Women with Diabetes. Stress and Health, in press 2) Reviews, Guideline documents, Editorials, Book Chapters: 1. Lampert R : Long-term management of atrial fibrillation: Maintenance of sinus rhythm vs. rate control and anticoagulation; American Journal of Geriatric Cardiology 1998; 7:33-42. 2. Ezekowitz M, and Lampert R: Pharmacological Control of Rate and Maintenance of Sinus Rhythm; Journal of Thrombosis and Thrombolysis 1999; 7:33-38. 3. Lampert R, Ezekowitz M: Management of Arrhythmias; In: Clinics in Geriatric Medicine. 2000;16:593-618. 4. Goldberger, Z, Lampert, R. Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies; JAMA 2006; 295:809-818. 5. Carlson, MD, Willcoff, BS, Maisel, WH, Ellenbogen, KA, Saxon, LA, Prystowsky, EN, Alpert, JS, Cain, ME, Ching, EA, Curtis, AB, Davies, DW, Hammill, SC, Hauser, RG, Lampert, R, Zipes, DP: Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines; Heart Rhythm Journal 2006; 3:1250-1273. 6. Lampert, R: Implantable Cardioverter-Defibrillator Use and Benefit in Women; Cardiology in Review, 2007; 15: 298-303 7. Lampert, R: Atrial Fibrillation in Athletes: Toward better understanding and more effective therapy; J Cardiovasc Electrophys, 2008; 19:463-5. (editorial) 8. Lampert R, Cannom D: Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision. Heart Rhythm 2008; 5:861-3. (“Conflicts in cardiology” section invited editorial) 9. Maisel, WH, Hauser, RG, Hammill, SC, Ellenbogen, KA, Epstein, AE, Hayes, DL, Alpert, JS, Berger, RD, Curtis, AB, Dubin, AM, Estes, NAM, Gura, MT, Krahn, AD, Lampert, R, Lindsay, BD, Wilkoff, BL: Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines; Heart Rhythm, 2009, 6: 869-885. 10. Lampert, R: Emotion and sudden cardiac death; Expert Review Cardiovascular Therapeutics, 2009,7:723-25 11. Shusterman, V, Lampert, R, London, B: The many faces of repolarization instability: Which one is prognostic; J Electrocardiology, 2009, 42:511-6 12. Lampert, R: Anger and ventricular arrhythmias; Current Opinion in Cardiology, 2010, 25:46-52 13. Lampert, R and Goldberger, J: Implantable Cardioverter Defibrillators. In, Device Therapy in Heart Failure, Editor Maisel, WH, Humana Press, p 155-185 14. Lampert, R , Hayes, DL, Annas, GJ, Farley, MA, Goldstein, NE, Hamilton, RM, Kay, GN, Kramer, DB, Mueller, PS, Padeletti, L, Pozuelo, L, Schoenfeld, MH, Vardas, PE, Wiegand, DL, Zellner, R: HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm, 2010; 7:1008-1026 15. Lampert, R: Air pollution and repolarization heterogeneity: More impetus for alternative energy. J Am Coll Cardiol, 2011; 57: 207-209 (editorial) 16. Lampert, R, and Saul, P: The athlete with an implanted device: Implantable cardioverterdefibrillators and pacemakers. In, Sports Cardiology in Practice, Editor, Lawless, C, Springer,2011 17. Lampert, R: Use of antiarrhythmic medications in women. European Cardiology, 2010. 6: 70-73 18. Lampert, R: Survival of ICD patients in the era of remote-monitoring: The five- thousand foot, highAltitude view. Circulation. 2010;122:2353-2355 (editorial) 19. Padeletti, L, Arnar, David O., Boncinelli, L, Brachman, J, Camm, J., Daubert, J, Kassam, S., Deliens, L., Glikson, M., Dayes, D., Israel, C., Lampert, R., Lobban, T., Raatikainen, P., Siegal, G., Vardas, P: EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace, 2010. 12(10):1480-9, 2010 Oct 20. Lindsay, BD, Asirvatham, SJ, Curtis, AB, Gura, MT, Hayes, DL, Jalife, J, Klein, GJ, Knight, BP, Lampert, R, Natale, A, Packer, DL, Page, RL, Scheinman, MM, Shanker, AJ, Wang, PJ, Weiss, JP, Wilkoff, BL, Busky, CD: Guidance for the Heart Rhythm Society Pertaining to Interactions with Industry: Endorsed by the Heart Rhythm Society on April 26, 2011, Heart Rhythm, 2011. 8: e19-e23 21. Lampert, R: Evaluation and management of arrhythmia in the athletic patient. Progress in Cardiovascular Diseases, 2012. 54: 423-431. 22. Lampert, R, Olshansky, B: Sports participation in patients with implantable cardioverter– defibrillators. Herzschrittmachertherapie + Elektrophysiologie, 2012, 23:87–93 23. Lampert, R: Put on a Happy Face—It’s a Lot Better than Coumadin; JAHA, 2012, in press (editorial) 24. Lampert, R: Primary prevention ICDs—They work in the real world too. Circulation: Arrhythmias and Electrophysiology, 2012; 5: 624-625 doi: 10.1161/CIRCEP.112.974907 (editorial) 25. Lampert, R and Hayes, D. Ethical issues in pacemaker and implantable cardioverter-defibrillator therapy. In, Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy, Ed Ellenbogen, Kay, Lau, and Wilkoff; Elsevier, 2011 (book chapter) 26. Lampert, R: Quality of Life and End-Of-Life Issues for Older Patients with Implanted Cardiac Rhythm Devices. In, Clinics in Geriatric Medicine: Cardiac Rhythm Disorders in Older Adults, 2012, p 693-702. 27. Corrine Jurgens, Sarah Goodlin, Mary Dolansky, Ali Ahmed, Ross Arena, Lenore Blank, Harleah Buck, Kerry Cranmer, Gregg Fonarow, Rebecca Boxer, Jerome Fleg, Rachel Lampert, Terry Lennie, JoAnn Lindenfeld, Ileana Pina, Todd Semla, Patricia Trebbien, and Michael Rich: Heart Failure Management in Skilled Nursing Facilities, Circulation, in press 28.[AUC] 29. Lampert, R: Managing with Pacemakers and ICDs, Circulation, 2013, in press (review) 30. Lampert, R: Is Electricity Useful when the Pump is Failing? More Data Urgently Needed, JACC, 2013, in press (editorial) 3) Published abstracts 1. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C: Circadian Variation of Sustained Ventricular Tachycardia in Patients with Coronary Artery Disease and Implantable CardioverterDefibrillators. PACE 1994; 17:834. 2. Lampert R, Rosenfeld L, VanZetta A, Lewis R, McPherson C, Batsford W, for the CPI PRXII Investigators: Initial Multicenter Experience with a New Third-Generation Cardioverter-Defibrillator, the CPI PRxII. PACE 1995; 18:889. 3. Lampert R, McPherson CA, Lewis RJ, Batsford WP, Rosenfeld LE: Inappropriate Sensing of Atrial Stimuli in Patients with a Third Generation Defibrillators and DDD Pacemakers. J Am Coll Cardiol 1996; 27:348A. 4. Lampert R, Denner A, Sreenivasan D, Rosenfeld L, Lee R: Diurnal Variation of Heart Rate Fractal Dimension in Heart Disease Patients. J Am Coll Cardiol 1996; 27:95A. 5. Lampert R, Jain D, Burg M, Batsford W, McPherson C: Effects of Mental Stress on Ventricular Arrhythmias in Patients with Ventricular Tachycardia and Implantable Defibrillators. Circulation 1996; 94:I-568 6. Lampert R, Ickovics J, Viscoli C, Rosenfeld L, Horwitz R, Lee F: The Effect of Beta-blockers on Recovery of Heart Rate Variability in the Beta-Blocker Heart Attack Trial (BHAT). J Am Coll Cardiol 1997; 29:176A. 7. Lampert R, Denner A, Rosenfeld L, Lee FA: Diurnal Change in Fractal Dimension Differs Between Heart Disease Patients and Normal Individuals. PACE 1997; 20:1157. 8. Lampert R, Ickovics J, Viscoli C, Rosenfeld L, Horwitz R, Lee F: Inter-relationship between Effect on Heart Rate Variability and Effect on Outcome by Beta-blockers in the Beta-Blocker Heart Attack Trial (BHAT). Circulation 1998; 98: I-80. 9. Lampert R, Clancy J, McPherson C, Rosenfeld L, Batsford W; Gender Differences in Ventricular Arrhythmia Recurrence in Patients with Implantable Cardioverter-Defibrillators. PACE 1998; 21:910. 10. Lampert R, Jain D, Burg M, Batsford W, McPherson C; Arousal State Influences Lethal Potential of Induced Ventricular Arrhythmias. PACE 1999; 22:749. 11. Burg MM, Malkin A, Lampert R, Jain D. Psychological factors in AICD pacing and discharge. Psychosom Med 1999;61:126. 12. Lampert R, McPherson C, Clancy J, Rosenfeld L, Batsford W: Gender Differences in Arrhythmia Recurrence in Patients with Implantable Cardioverter-Defibrillator and Coronary Artery Disease. AHA 5/01 13. Lampert R, Joska T, Burg, M, Batsford W, McPherson C, Jain D: Anger, Anxiety, and Physical Stress Precipitate Ventricular Arrhythmias in Patients with Implantable Cardioverter-Defibrillators. PACE 2002; 24: 686 14. Lampert R, Baron S, McPherson C, Lee F: Long-Reaching Effects of Terrorism: Altered Heart Rate Variability During and After September 11, 2001. PACE 2002; 24: 630 15. Goldberger Z, Rosenfeld L, Batsford W, McPherson C, Lampert R: Combining Clinical and Electrophysiologic Criteria Effectively Determines the Need for Dual-Chamber Device in Patients Receiving Implantable Cardioverter Defibrillators. PACE 2002; 24: 664 16. Schreibman, Rosenfeld, McPherson, Batsford, Lampert: The utility of Procainamide challenge in Electrophyiologic Risk Assessment. J Am Coll Cardiol 2002; 39:117A 17. Burg MM, Joska T, Lampert R, Batsford W, Jain D.: Anger, anxiety and physical stress precipitate ventricular arrhythmias in patients at high risk. Psychosom Med 2002;64:100. 18. Lampert R, Ickovics J, Horwitz R, Lee F: Heart Rate Variability Is Depressed in Conditions of Chronic Socioeconomic Stress. PACE, 2003; 26:1111 19. Lampert R, Burg M, Lee F, Earley C, McPherson CA, Batsford W, Soufer R: Autonomic Impact of Shock and Anger-Reactivity in Patients with Implantable Cardioverter-Defibrillators. PACE, 2003; 26:1015 20. Lampert R, Goldberger Z, Elbel B, Batsford W, McPherson C, Paltiel AD: Cost Advantage of Dual versus Single Chamber Defibrillator Implantation. PACE, 2003; 26:982 21. Lampert, R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP: Ventricular Arrythmia Recurrence and Frequency are Lower in Women Than Men with Coronary Artery Disease and Implantable Cardiverter Defibrillators. Circulation 2003; 108:IV-386 22. Davids JS, McPherson CA, Earley C, Rosenfeld LE, Clancy JF, Lampert R: Safety of Sports and Vigorous Exercise in Patients with Implantable Cardioverter-Defibrillators. Circulation 2003; 108:IV616 23. Davids JS, McPherson CA, Earley C, Batsford WP, Grubman E, Lampert R: Benefits of Cardiac Rehabilitation in Patients with Implantable Cardioverter-Defibrillators. Circulation 2003; 108:IV-740 24. Vaccarino V, Lampert R, Lee F, Bremner JD, Abramson J, Murrah N, Afzal N, Cheema F, Goldberg J: Depressive Symptoms are Associated with Reduced Heart Rate Variability in Individuals without Coronary Artery Disease. JACC 2004; 43:120A. 25. Whang W, Albert C, Lampert R, Sears S, Conti J, Wang P, Ruskin J, Muller J, Mittleman M: A Multicenter Study of Depression as a Predictor for Appropriate Shocks Among Patients with Implantable Cardioverter-Defibrillators. JACC 2004; 43: 116A. 26. Lampert, R, Shusterman, V, Burg, M, Lee, F, Earley, C, Goldberg, A, McPherson, C, Batsford, W, Soufer, R: Psychological Stress Increases Heterogeneity of Repolarization in Patients with Structural Heart Disease and Ventricular Arrhythmias. JACC 2004; 43:140A. 27. N.E. Goldstein, R. Lampert, E.H.Bradley, J. Lynn, H.M. Krumholz. Deactivation of Implantable Cardioverter-Defibrillators at the End of Life. Journal of the American Geriatrics Society. 2004; Vol 52, Number 4, S4. 28. Vashist, A, Arrighi, J, Lampert, R, Burg, M, Soufer, R. Differential Impact of Parasympathetic Withdrawal to Mental Stress Ischemia as Assessed by Noninvasive Evaluation of Myocardial Perfusion and/or Function. Accepted, ASNC, October 2004 29. Brennan, P, McPherson, CA, Batsford, WP, Rosenfeld, L, Clancy, J, Lampert, R. QRS Width: A Limited Predictor of Arrythmia Recurrence in Patients with CAD and ICDs. Heart Rhythm. 2004; 1:S24. 30. Vaccarino, V, Lampert, R, Lee, F, Bremner, JD, Maisano, C, Abramson, JL, Murrah, N, Cheema, F, Goldberg, J. Heart Rate Variability, a Measure of Autonomic Dysfunction, is Associated with Insulin Resistance. Presented, AHA 11.04 31. Lampert, R, Cannom, D, Olshansky, B: Safety of Sports in Patients with Implantable Cardioverterdefibrillators: A Survey of NASPE-Heart Rhythm Society Members. Circulation, 2004. 110:III-626 32. Stopper MM, Jain D, Burg MM, Joska T, McPherson C, Batsford W, Lampert R. Electrophysiological characteristics of anger-triggered arrhythmias. Heart Rhythm, 2005; 2:S162 33. Mahoney T, Clancy J, McPherson C, Rosenfeld L, Batsford W, Lampert R. Ejection Fraction is a Poor Predictor of Recurrent Arrhythmia in Patients Receiving ICDs for Primary Prophylaxis. Heart Rhythm, 2005; 2:S244 34. Naidu, S, Shusterman, V, Howes, C, Cleman, M, O’Connor, M, Goldberg, A, Lampert, R. T-wave amplitude is a more sensitive marker of myocardial ischemia than ST-segment changes patients undergoing exercise stress testing. Heart Rhythm, 2006; 3:S273 35. Lampert, R, Bremner, JD, Su, S, Miller, AH, Lee, FA, Cheema, F, Goldberg, J, Vaccarino, V. Decreased heart rate variability, a measure of autonomic dysfunction, is associated with higher levels of inflammation as measured by IL-6. Circulation, 2006, 114: II-471 36. Lampert, R, Soufer, R, McPherson, CA, Batsford, WP, Tirado, S, Earley, C, Goldberg, A, Shusterman, V. Implantable cardioverter-defibrillator shocks increase T-wave alternans. Circulation, 2006, 114: II-475 37. Vaccarino, V, Lampert, R, Lee, F, Bremner,JD, Su, S, Cheema, FA, Goldberg, J. Depression and heart rate variability: Is there a common genetic pathway? Circulation, 2006, 114: II-556 38. Albert, CM, Lampert, R, Conti, JB, Chung, MK, Wang,PJ, Muller, JE, Mittelman, MA. Episodes of anger trigger ventricular arrhythmias in patients with implantable cardioverter-defibrillators. Circulation, 2006, 114: II-831 39. Bui, V, Huynh, M, Lampert, R. Physician management of Brugada syndrome in Vietnam. Heart Rhythm, 2007, 4: S265 40. Lampert, R., Shusterman, V, Burg, M, Batsford, W, McPherson, C, Soufer, R. Anger, alternans, and arrhythmia: Anger-induced TWA predicts future ventricular arrhythmias in patients with ICDs. JACC, 2008, 51:A32 41. Soufer, A, Ranjbaran, H, Graeber, B, Burg M, Liu, J, Lampert, R, Tellides, G, Collins, D, Soufer, R. Parasympathetic withdrawal and sympathetic arousal during anger correlate with elevated endothelin-1 in patients with coronary artery disease (APS March 2008) http://www.psychosomaticmedicine.org/misc/TotalAbstractBook.pdf 42. Hauser, RG, Maron, BJ, Kadish, A, Marine, JE, Lampert, R, Scher, DL, Biria, M, Winters, S, Cunnane, R, Amit, K. Performance of high voltage implantable cardioverter defibrillator leads in hypertrophic cardiomyopathy: A multicenter study. Heart Rhythm, 2008, 5:S192 43. Gravelin, LM, Remetz, M, Radford, M, Lampert, R: Use of a screening tool improves appropriate referral for implantable cardioverter-defibrillators for primary prevention. Circulation, 2008, 118: S595. 44. Lampert, R, Burg, M, Brandt, C, Dziura, J, Liu, H, Donovan, T, Soufer, R, Jamner, L: Impact of emotions on triggering of atrial fibrillation. Circulation, 2008: 118: S640. 45. Leubbert, J, Hammill, S, Wang, Y, Rathore, SS, Lampert, R, Krumholz, H, Hendenreich, P, Curtis, JP: Association of implanting physician certification with complications following implantable cardioverter-defibrillator procedures: Insights from the ICD Registry. Circulation, 2008, 118: S926. 46. Curtis, JP, Leubbert, J, Wang, Y, Lampert, R, Rathore, SS, Hammill, S, Heidenreich, P, Krumholz, H.: Association of implanting physician certification with rates of CRT-D implantation in eligible patients: Insights from the ICD Registry. Circulation, 2008, 118: S950 47. Dai J, Lampert R, Wilson PW, Goldberg J, Ziegler TR, Vaccarino V. Adherence to the Mediterranean diet is associated with improved cardiac autonomic function among middle-aged men. Circulation. 2009;119(10):e294 48. Lampert R, Salberg L, Burg M. Emotional Stress Triggers Symptoms in Individuals With Hypertrophic Cardiomyopathy: A Survey of the Hypertrophic Cardiomyopathy Association (HCMA). Circulation, 2009;120:S495. 49. Lampert R, Wang Y, Curtis J. Factors Influencing the Use of Higher-Tech/Higher Cost Implantable Cardioverter-Defibrillators: Data From the NCDR ICD Registry. Circulation, 2009; 120: S437 - S438. 50. Bhatt, PS, Curtis, J, Wang, Y, Lampert, R. Impact of the Medtronic Fidelis Lead Recall on Utilization of Implantable Cardioverter-defibrillators: Data from the NCDR ICD Registry. J Am Coll Cardiol, 2010; 55: A14. 51. Razak, E, Buncova, M, Shusterman, V, Winter, B, Shen, W, Ackerman, M, Donovan, T, Lampert, R, Nemec, J. Slow QT interval adaptation to heart rate change in normal ambulatory subjects. Heart Rhythm, 2010; 7: S174 52. Yuhas, J, Mattocks, K, Gravelin, L, Remetz, M, Foley, J, Fazio, R, Lampert, R. Patient attitudes and perceptions of implantable cardioverter-defibrillators: Potential barriers to appropriate primary prophylaxis. Heart Rhythm, 2011; 53. Rajeswaran, Y, McNamara, RL, Curtis, J, Lampert, R: Identification of Potential Candidates for Implantable-Cardioverter-Defibrillators (ICDs) for Primary Prevention via Echocardiography Screening. QCOR, 2011 54. Lampert, R, Tuit, K, Sinha, R: Chronic stress and adverse life events are associated with depressed autonomic function as measured by heart rate variability. Presented AHA, 2011 55. John A. Dodson, Jeptha P. Curtis, Yongfei Wang, Stephen C. Hammill, Paul Varosy, and Rachel Lampert Temporal trends in quality of care among ICD recipients: Insights from the NCDR ICD Registry J Am Coll Cardiol 2012 59: E581 56. Dodson JA, Fried T, Van Ness PH, Goldstein N, Lampert R. Preferences for deactivation of implantable cardioverter defibrillators in the setting of advanced illness (oral presentation). AGS 2012. 57. Mandawat, A, Curtis, JP, Njike, V, Lampert, R; Safety of pacemaker implantation in nonagenarians. Presented QCOR 2012 58. Russo, AM, Wang, Y, Curtis, J, Al-Khatib, S, Lampert, R. Contemporary Patterns of Practice and Characteristics of Patients undergoing Defibrillation Testing versus those who do not undergo Testing at the Time of Initial ICD Implant: Analysis of the NCDR ICD Registry (presented ACC 2012) 59. Russo, R, Costa, HS, Doud, D….Lampert, R…Arsha, A. Determining the Risks of MRI at 1.5 Tesla for Patients with Pacemakers and Implantable Cardioverter-Defibrillators. Presented AHA, 2012 60. Russo, AM,…Lampert, R. Gender and Outcomes following primary prevention ICD placement: Analysis of the NCDR ICD Registry. Presented AHA 2012 61. Russo, AM….Lampert, R. Predictors of high defibrillation energy requirements: Results from the NCDR ICD Registry. Presented AHA 2012 62. Rosman, L., Cutitta, K., Ford, J., Derian, L., Cahill, J., Lampert, R., Mosesso, V., N., Lawless, C., & Sears, S., F. (July, 2013). Sex differences in prodromal symptoms of sudden cardiac arrest and long-term psychosocial adjustment: The unmet needs of female survivors. The Society for Women's Health Research Meeting, What a Difference an X Makes: The State of Women's Health Research, Washington, DC. Invited Lectures: 5/30/13, Indianapolis, IN, American College of Sports Medicine (ACSM) symposium speaker, “Is it safe for patients with ICDs to participate in sports?” 5/9/13, Denver, CO, HRS, symposium speaker, “Safety of sports for patients with ICDs” 5/10/13, Denver, CO, HRS, symposium speaker, “When is it appropriate to turn off ICD therapies in a terminally ill patient” 5/11/13, Denver, CO,HRS, “meet the experts”, “Optimizing identification of primary prevention ICD candidates” 3/9/13, San Francisco, CA, ACC, symposium speaker, “Treatment options for atrial fibrillation: Are there differences for the active patient? 3/11/13, San Francisco, CA, ACC, symposium speaker, “Does my dynamic 83 yo HFREF patient need an ICD” 2/9/13, San Diego, CA, St Jude Medical “Women in EP Symposium”, “Clinical research on treatment options for SCA in young athletes” 12/7/12, Los Angeles, CA, Cedar Sinai Arrhythmia Symposium, “Implantable cardioverter defibrillators and end of life issues”. 11/5/12, Los Angeles, CA, AHA, session chair, “Controversies in ICD Management: Lead Advisories, MRI, DFTs” 10/17/12, Kunming, China, Chia Fellowship Conference, “Chronic stress and chronic disease” 10/19/12, Kunming, China, Kunming Medical University Internal Medicine Grand Rounds, “Mental stress and sudden cardiac death” 9/10/12, Seattle, WA, Heart Failure Society of America (HFSA), “Management of cardiac devices in nursing homes” 8/19/12, Kansas City, MO, Kansas City Heart Rhythm Symposium, “Mental stress and ventricular arrhythmias: the mind-body connection” 5/9/12, Boston, MA, HRS, Symposium speaker, “When to deactivate a cardiac rhythm device” 5//10/12, Boston, MA, HRS, session chair and speaker, “meet the experts” “When ICD issues are not black and white” 11/14/11, Orlando, Fla, AHA, “Who and How should Cardiac Implantable Electronic Devices be Deactivated?” 10/11/11 San Diego, CA, Medtronic “Women in EP” conference: Deactivation of Implantable Devices at Patients’ End of Life 5/5/11, San Francisco, CA, HRS, panelist, “HRS Policies on Relationships with Industry” 5//11, San Francisco, CA, HRS, session chair, “The latest in ICD lead and generator technology” 5/6/11, San Francisco, CA, HRS, session chair, “Defibrillation testing: a necessity or just risky?” 4/3/11, New Orleans, LA, ACC, “Clinical cardiology spotlight: Real world cases in sports cardiology”, panelist 4/411, New Orleans, LA, ACC “meet the experts”, “My patient wants me to turn off their cardiac rhythm device”, session chair 10/18/10, Washington, DC, NIH/NCCAM series, “Psychological Stress and Sudden Cardiac Death” 10/2/10, Miami, Florida, Medtronic “Women in EP” conference: “Gender Bias in Device Implantation” 9/14/10, Atlanta, Georgia, National Hospice and Palliative Care Organization 11th Clinical Conference, “Deactivation of Cardiac Rhythm Devices at Patients’ End of Life” 5/13/10, Denver, CO, HRS, “Gender differences in ICD therapy: Does bias exist?” (core curriculum) 5/14/10, Denver, CO, HRS, “It is always appropriate to turn off a CIED if requested by a competent patient (protagonist)”, debate 3/13/10, Atlanta, GA, ACC CCCOA (council on cardiovascular care for older adults) symposium: “An 87 year old woman with arrhythmia: the patient-centered perspective” 3/15/10, Atlanta, GA, ACC, “meet the experts”, “Evaluating arrhythmias in athletes” 3/15/10, Atlanta, GA, ACC, “Psychology of cardiac arrhythmias” 9/19/09, Los Angeles, CA, Boston Scientific program, Women In EP, “Athletes and arrhythmias” 9/13/09, New York, NY, Boston Scientific program, Advanced Forum for Heart Failure and EP, “Athletes and arrhythmias” 6/22/09, Berlin, Germany, Europace (European Heart Rhythm Association Scientific Sessions), “Deactivating the ICD, Ethical Considerations, US Viewpoint” 6/22/09, Berlin, Germany, Europace, “Effectiveness of anti-arrhythmic therapy in females” 6/23/09, Berlin, Germany, Europace, “Mechanisms of atrial fibrillation in athletes” 5/13/09, Boston, MA, Heart Rhythm Society, Symposium, “Management of cardiac devices at patients’ end of life: Why is this an issue to be addressed?” 1/9/09, Washington, DC, Medtronic sponsored conference, Women Physicians in Electrophysiology, “Athletes and ICD therapy: An update on the ICD Sports Registry” 7/27/08, Toronto, 14th World Congress on Heart Disease, “Role of psychological factors in triggering ventricular arrhythmias” 5/15/08, San Francisco, CA, Heart Rhythm Society, core curriculum, “Use of the NCDR ICD Registry Data to Evaluate Practice Patterns” 5/16/08, San Francisco, CA, Heart Rhythm Society, debate (protagonist), “Young persons with ICD for primary prevention can participate in non-contact competitive sports” 3/13/08, Baltimore, MD, American Psychosomatic Society Scientific Sessions symposium: “Psychological Stress and Arrhythmogenesis”. 2/9/08, Washington, DC, American College of Cardiology Symposium, “The Heart of Women’s Health”, speaker, “Are ICDs as effective in women?” 12/13/07, Boston, MA, ICD Lead Performance Conference, Beth Israel Medical Device Institute, speaker and panelist, “Clinical Management and Communication of ICD Lead Performance Issues” 11/ 7/07, Orlando, Florida, American Heart Association Scientific Sessions “symposium”: “How to discontinue cardiac devices at end-of life” 5/12/07, Denver, CO, Heart Rhythm Society “core curriculum”: Device Recalls: Overreaction or LevelHeaded Decision-Making? 5/10/07, Denver, CO, Heart Rhythm Society “meet the experts”: Triggers of arrhythmia: Ischemia, Exercise, and Emotions 5/4/07: Hartford, CT, Hartford Hospital Cardiology/Exercise Physiology Journal Club, “Safety of Sports for Patients with ICDs” 3/26/07: New Orleans, LA, American College of Cardiology, “meet the experts”, “Cardiac rhythm devices: Regulatory issues” 11/11/06, Chicago, Ill, American Heart Association, Heart Disease in Women Symposium, “ICD use and effectiveness in women” 11/11/06, Chicago, Ill; PRICE symposium (Society for Geriatric Cardiology), “End of Life Care: When to disable implanted devices” 10/13/06, Chicago, Ill, Cook County Hospital Internal Medicine Grand Rounds, “Implantable cardioverter-defibrillators: Expanding indications and technologies 5/19/06, Boston, MA, Heart Rhythm Society, “meet the experts”, “The 36th Bethesda conference guidelines: what the clinician needs to know” 5/19/06, Boston, MA, Heart Rhythm Society, core curriculum, “Communicating uncertainties and complexities with patients [re device performance]” 5/18/06, Boston, MA, Heart Rhythm Society, “meet the experts luncheon”, “Cardiovascular screening for sports participation” 5/17/06, Boston, MA, Heart Rhythm Society, panelist, “Town Hall on Device Performance” 3/06, Atlanta, GA, American College of Cardiology, core curriculum, “Psychological aspects of implantable cardioverter-defibrillator therapy” 11/14/05, Dallas, Tx, American Heart Association, “Meet the experts luncheon”, “Sports participation for the athlete with cardiovascular disease and an implantable device” 10/08/05, Chicago, Illinois, Medtronic-sponsored conference “Women in Heart Failure”, debate, “All patients receiving cardiac resynchronization therapy should receive an ICD” 9/16/05, Washington, DC, Heart Rhythm Society Policy Conference on Pacemaker and ICD Performance, speaker, “Role of the physician in device surveillance” 3/22/05, University of Pittsburgh, Pittsburgh, PA, Cardiology Grand Rounds, “Sudden death at the casino: Psychological stress and arrhythmias” 3/7/05, Orlando, Florida, American College of Cardiology, symposium speaker, “Quality of life after device placement” 1/28/05, Emory University, Atlanta, Georgia, Cardiology conference “Psychological stress and arrhythmias” 10/27/04, Middletown, CT,: Atrial Fibrillation Roundtable, panelist, CT chapter ACC 5/2001: Boston, MA, North American Society of Pacing and Electrophysiology “Right Ventricular Outflow Tract Tachycardia”. 11/1999: Atlanta, Georgia, American Heart Association “How to Manage Atrial Fibrillation in the Elderly” Yale Cardiology International Symposium; “Update on ICDs” 9/30/99, 10/14/99, 10/26/99 Yale International Symposium on Contemporary Management of the Cardiovascular Patient-10/15/97 and 10/22/97 8/12/97, New Haven, CT, Pilot Pen Course: “Role of Pacing in Atrial Fibrillation”- Other Media presentations/publications 9/18/09: New Haven, CTV “One World Progressive Institute 21st Century Conversations”: “Sudden Cardiac death” Lampert, R: Mental Stress and Ventricular Arrhythmias; CCACC electronic newsletter, 4.18.07 5/17/07, New Haven, CTV “One World Progressive Institute 21st Century Conversations”: “Women, and Heart Disease” 5/8/2008, New Haven, CTV “One World Progressive Institute 21st Century Conversations”: “Women, Stress, and Heart Disease” Program committee, session chair Toronto, 14th World Congress on Heart Disease, program committee 7/27/08, Toronto, 14th World Congress on Heart Disease, session chair, “Arrhythmias I” Session chair 5/13/09, Boston, MA, Heart Rhythm Society, Symposium, Management of cardiac devices at patients’ end of life 5/16/09, Boston, MA, Heart Rhythm Society, core curriculum, 5/13/10, Boston, MA, HRS, “expert commentator”, session “Advances and Insights into health policy and education” 5/14/10, Denver, CO, Heart Rhythm Society, “Expert consensus on management of cardiac devices at patients’ end of life” Research Support Ongoing 1R01HL89340-01 (Lampert, PI) 25% T-wave alternans and emotion in daily life 5/1/08-5/30/13 The goals of this study are to evaluate whether T-wave alternans measured via 24-hour ambulatory ECG is associated with emotion states as assessed by experience sampling, and whether these changes correlate with increased arrhythmia risk, in patients with ICDs. Industry Funded/Investigator Initiated Guidant, Medtronic, St. Jude “ICD Sports Safety Registry” (Lampert, PI,) 5% 1 R01 HL071116-01 (Soufer PI) 5% NIH National, Heart, Lung and Blood Institute "CV Responses to Mental Stress: Mechanistic Considerations" 2006-2014 9/15/08-9/14/12 This study is evaluating mechanisms of mental-stress induced ischemia. As co-investigator, my role is analysis of heart-rate variability, with the overall goal of determining the role of autonomic nervous system in the pathway from emotion to CNS to heart. Interdisciplinary Research Consortium (Sinha PI) 5% Human Subjects Core (P30) Interdisciplinary Research Consortium (Potenza PI) 5% fMRI of Stress & Self-Control in Smoking & Obesity 9/30/07 - 09/29/12 9/30/07 - 09/29/12 As co-investigator on this project, my role is analysis of heart rate variability, towards the goal of evaluating whether addictive disorders alter autonomic nervous system function. 1R01HL084438-01A1 (PI, Matthew Burg, PhD,) 20% NIH/NHLBI Reducing Vulnerability to ICD Shock Treated Ventricular Arrhythmias 9/1/07-8/30/1 This recently-funded study will randomize patients receiving ICDs to receive stress reduction therapy versus usual care to determine whether SRT will reduce occurrence of potentially life-threatening arrhythmias. A co-investigator, my role is to oversee all medical aspects of this study. 1R01HL089314-01 (PI, Levy) 10% Racial disparities in heart attach recovery: Role of stigma and stress 7/1/08-6/30/12 The goal of this study is to evaluate the role racial and age stigma in recovery after myocardial infarction. My roles are to provide consultation and coordination regarding cardiac clinical care, overseeing all medical aspects of the study, and to perform heart rate variability analysis, to evaluate the role of the autonomic nervous system in any associations seen. 1 U34 HL105285-01 (PI, Yaggi) 5% Sleep Apnea in TIA: Reducing Vascular Risk with AutoPAP (“SLEEP TIGHT”). 2R01HL068630-06A2 (PI, Vaccarino) Mechanisms Linking Depression to Cardiovascular Risk 5% 9/10-8/15 8/17/09 - 7/31/11 As co-investigator on this project, now funded for continuation, my role is analysis of heart rate variability, towards the goal of evaluating whether depression alters autonomic nervous system function now being investigated prospectively. 02/07/2011 – 1R01HL102084-01A1 (PI, Goldstein) consultant 01/31/2016 An Intervention to Improve Conversations About ICD Deactivation My role as a consultant on this project is to provide advice regarding defibrillator functions and the logistics of working with ICD patients Completed SDG 0030190 Lampert, R. (PI) American Heart Association Scientist Development Grant “Mental Stress and Ventricular Arrhythmias” 1/2000-1/2004 direct costs 260,000 This goal of this study is first, to evaluate, whether mental-stress reactivity is predictive of arrhythmia recurrence in patients with implantable cardioverter-defibrillators, and second, to evaluate potential mechanisms of stress-induced arrhythmia. 1R01 HL68630-01 Vaccarino (PI) NIH/NHLBI. "Mechanisms Linking Depression to Cardiovascular Risk” Lampert, R. (Co-Investigator) (10%) 06/01/2001-05/31/2006 As co-investigator on this project, my role is analysis of heart rate variability, towards the goal of evaluating whether depression alters autonomic nervous system function. 1R01 HL073285-01A1 (Lampert, PI) NIH/NHLBI “Emotional reactivity: A trigger of Atrial Fibrillation” 25% 05/01/04-04/30/09 direct costs 1,250,000 The goals of this study are to evaluate first, whether, emotional states can trigger atrial fibrillation, and second, whether stress-reactivity is a predictor of recurrent events, in patients with a history of atrial fibrillation Industry Sponsored (Lampert, PI,) 1% Medtronic Patient barriers to primary prevention ICD implantation 2009-10